181 related articles for article (PubMed ID: 22430275)
1. Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors.
Caan BJ; Emond JA; Su HI; Patterson RE; Flatt SW; Gold EB; Newman VA; Rock CL; Thomson CA; Pierce JP
J Clin Oncol; 2012 May; 30(13):1492-7. PubMed ID: 22430275
[TBL] [Abstract][Full Text] [Related]
2. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
Su HI; Sammel MD; Springer E; Freeman EW; DeMichele A; Mao JJ
Breast Cancer Res Treat; 2010 Nov; 124(1):205-11. PubMed ID: 20182796
[TBL] [Abstract][Full Text] [Related]
3. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study.
Lipov EG; Joshi JR; Sanders S; Wilcox K; Lipov S; Xie H; Maganini R; Slavin K
Lancet Oncol; 2008 Jun; 9(6):523-32. PubMed ID: 18485819
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.
Elkins G; Marcus J; Stearns V; Perfect M; Rajab MH; Ruud C; Palamara L; Keith T
J Clin Oncol; 2008 Nov; 26(31):5022-6. PubMed ID: 18809612
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
6. Stellate-ganglion block: a new treatment for hot flushes?
Loprinzi CL; Barton DL; Carns PE
Lancet Oncol; 2008 Jun; 9(6):506-7. PubMed ID: 18510982
[No Abstract] [Full Text] [Related]
7. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer survivors and hot flashes: the search for nonhormonal treatments.
Avis NE
J Clin Oncol; 2008 Nov; 26(31):5008-10. PubMed ID: 18809600
[No Abstract] [Full Text] [Related]
9. Using traditional acupuncture for breast cancer-related hot flashes and night sweats.
de Valois BA; Young TE; Robinson N; McCourt C; Maher EJ
J Altern Complement Med; 2010 Oct; 16(10):1047-57. PubMed ID: 20954961
[TBL] [Abstract][Full Text] [Related]
10. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
[TBL] [Abstract][Full Text] [Related]
11. Weight change and its correlates among breast cancer survivors.
Chen X; Lu W; Gu K; Chen Z; Zheng Y; Zheng W; Shu XO
Nutr Cancer; 2011; 63(4):538-48. PubMed ID: 21541900
[TBL] [Abstract][Full Text] [Related]
12. Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study.
Pierce JP; Natarajan L; Caan BJ; Flatt SW; Kealey S; Gold EB; Hajek RA; Newman VA; Rock CL; Pu M; Saquib N; Stefanick ML; Thomson CA; Parker B
Am J Clin Nutr; 2009 May; 89(5):1565S-1571S. PubMed ID: 19339393
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
Raghavendra A; Sinha AK; Valle-Goffin J; Shen Y; Tripathy D; Barcenas CH
Clin Breast Cancer; 2018 Feb; 18(1):e7-e13. PubMed ID: 29239836
[TBL] [Abstract][Full Text] [Related]
14. Hot flashes and related outcomes in breast cancer survivors and matched comparison women.
Carpenter JS; Johnson D; Wagner L; Andrykowski M
Oncol Nurs Forum; 2002 Apr; 29(3):E16-25. PubMed ID: 11979290
[TBL] [Abstract][Full Text] [Related]
15. Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.
Haest K; Kumar A; Van Calster B; Leunen K; Smeets A; Amant F; Berteloot P; Wildiers H; Paridaens R; Van Limbergen E; Weltens C; Janssen H; Peeters S; Menten J; Vergote I; Morlion B; Verhaeghe J; Christiaens MR; Neven P
Ann Oncol; 2012 Jun; 23(6):1449-54. PubMed ID: 22039079
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
Barton DL; Loprinzi CL; Quella SK; Sloan JA; Veeder MH; Egner JR; Fidler P; Stella PJ; Swan DK; Vaught NL; Novotny P
J Clin Oncol; 1998 Feb; 16(2):495-500. PubMed ID: 9469333
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-induced hot flashes.
Loprinzi CL; Zahasky KM; Sloan JA; Novotny PJ; Quella SK
Clin Breast Cancer; 2000 Apr; 1(1):52-6. PubMed ID: 11899390
[TBL] [Abstract][Full Text] [Related]
18. Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors.
Sedjo RL; Byers T; Ganz PA; Colditz GA; Demark-Wahnefried W; Wolin KY; Azrad M; Rock CL
J Cancer Surviv; 2014 Sep; 8(3):410-8. PubMed ID: 24599421
[TBL] [Abstract][Full Text] [Related]
19. Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?
Nyrop KA; Deal AM; Lee JT; Muss HB; Choi SK; Wheless A; Carey LA; Shachar SS
Breast Cancer Res Treat; 2018 Jan; 167(1):235-248. PubMed ID: 28913660
[TBL] [Abstract][Full Text] [Related]
20. A hot flash on tamoxifen metabolism.
Goetz MP; Loprinzi CL
J Natl Cancer Inst; 2003 Dec; 95(23):1734-5. PubMed ID: 14652227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
